nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2C9—brain cancer	0.503	1	CbGaD
Eletriptan—CYP2D6—Lomustine—brain cancer	0.0525	0.238	CbGbCtD
Eletriptan—CYP2D6—Hydroxyurea—brain cancer	0.0398	0.18	CbGbCtD
Eletriptan—CYP3A4—Temozolomide—brain cancer	0.0392	0.178	CbGbCtD
Eletriptan—PTGS1—Etoposide—brain cancer	0.0344	0.156	CbGbCtD
Eletriptan—CYP3A4—Lomustine—brain cancer	0.0334	0.151	CbGbCtD
Eletriptan—ABCB1—Etoposide—brain cancer	0.0135	0.0609	CbGbCtD
Eletriptan—HTR1D—meninx—brain cancer	0.0102	0.0884	CbGeAlD
Eletriptan—HTR1F—trigeminal nerve—brain cancer	0.0102	0.0882	CbGeAlD
Eletriptan—HTR1B—dura mater—brain cancer	0.00969	0.084	CbGeAlD
Eletriptan—HTR1D—dura mater—brain cancer	0.00938	0.0813	CbGeAlD
Eletriptan—CYP3A4—Etoposide—brain cancer	0.00806	0.0365	CbGbCtD
Eletriptan—HTR1B—trigeminal nerve—brain cancer	0.00417	0.0361	CbGeAlD
Eletriptan—HTR1D—trigeminal nerve—brain cancer	0.00403	0.035	CbGeAlD
Eletriptan—HTR1F—ganglion—brain cancer	0.00367	0.0318	CbGeAlD
Eletriptan—HTR1B—cranial nerve—brain cancer	0.00297	0.0257	CbGeAlD
Eletriptan—HTR7—vein—brain cancer	0.0029	0.0252	CbGeAlD
Eletriptan—HTR1D—cranial nerve—brain cancer	0.00287	0.0249	CbGeAlD
Eletriptan—HTR1B—telencephalic ventricle—brain cancer	0.00241	0.0209	CbGeAlD
Eletriptan—HTR1D—telencephalic ventricle—brain cancer	0.00234	0.0203	CbGeAlD
Eletriptan—HTR7—cranial nerve—brain cancer	0.00229	0.0199	CbGeAlD
Eletriptan—HTR7—pons—brain cancer	0.00226	0.0196	CbGeAlD
Eletriptan—HTR1A—telencephalic ventricle—brain cancer	0.00195	0.0169	CbGeAlD
Eletriptan—HTR7—telencephalic ventricle—brain cancer	0.00186	0.0161	CbGeAlD
Eletriptan—HTR1B—ganglion—brain cancer	0.0015	0.013	CbGeAlD
Eletriptan—HTR1D—ganglion—brain cancer	0.00145	0.0126	CbGeAlD
Eletriptan—HTR1F—telencephalon—brain cancer	0.00141	0.0123	CbGeAlD
Eletriptan—HTR1E—brainstem—brain cancer	0.00138	0.012	CbGeAlD
Eletriptan—HTR1E—telencephalon—brain cancer	0.00123	0.0106	CbGeAlD
Eletriptan—HTR1A—ganglion—brain cancer	0.00121	0.0105	CbGeAlD
Eletriptan—HTR1B—blood vessel—brain cancer	0.00119	0.0104	CbGeAlD
Eletriptan—HTR7—ganglion—brain cancer	0.00116	0.01	CbGeAlD
Eletriptan—HTR1D—blood vessel—brain cancer	0.00116	0.01	CbGeAlD
Eletriptan—HTR7—endothelium—brain cancer	0.000999	0.00866	CbGeAlD
Eletriptan—HTR7—blood vessel—brain cancer	0.000922	0.00799	CbGeAlD
Eletriptan—HTR1A—hindbrain—brain cancer	0.00092	0.00797	CbGeAlD
Eletriptan—HTR1F—head—brain cancer	0.000881	0.00764	CbGeAlD
Eletriptan—HTR7—hindbrain—brain cancer	0.000879	0.00762	CbGeAlD
Eletriptan—HTR1F—central nervous system—brain cancer	0.000804	0.00697	CbGeAlD
Eletriptan—PTGS1—ganglion—brain cancer	0.000801	0.00694	CbGeAlD
Eletriptan—HTR1E—head—brain cancer	0.000763	0.00662	CbGeAlD
Eletriptan—HTR1E—central nervous system—brain cancer	0.000697	0.00604	CbGeAlD
Eletriptan—PTGS1—endothelium—brain cancer	0.000691	0.00599	CbGeAlD
Eletriptan—HTR1B—brainstem—brain cancer	0.000653	0.00566	CbGeAlD
Eletriptan—HTR1F—brain—brain cancer	0.000638	0.00554	CbGeAlD
Eletriptan—PTGS1—blood vessel—brain cancer	0.000637	0.00552	CbGeAlD
Eletriptan—HTR1D—brainstem—brain cancer	0.000632	0.00548	CbGeAlD
Eletriptan—HTR1B—telencephalon—brain cancer	0.00058	0.00503	CbGeAlD
Eletriptan—HTR1D—telencephalon—brain cancer	0.000561	0.00487	CbGeAlD
Eletriptan—HTR1E—brain—brain cancer	0.000553	0.00479	CbGeAlD
Eletriptan—HTR1A—brainstem—brain cancer	0.000527	0.00457	CbGeAlD
Eletriptan—HTR2B—telencephalon—brain cancer	0.000522	0.00453	CbGeAlD
Eletriptan—HTR7—brainstem—brain cancer	0.000504	0.00437	CbGeAlD
Eletriptan—CYP2D6—hindbrain—brain cancer	0.000499	0.00433	CbGeAlD
Eletriptan—HTR1A—telencephalon—brain cancer	0.000468	0.00406	CbGeAlD
Eletriptan—HTR7—telencephalon—brain cancer	0.000447	0.00388	CbGeAlD
Eletriptan—HTR1B—midbrain—brain cancer	0.000416	0.00361	CbGeAlD
Eletriptan—HTR1B—spinal cord—brain cancer	0.000406	0.00352	CbGeAlD
Eletriptan—HTR1D—midbrain—brain cancer	0.000403	0.00349	CbGeAlD
Eletriptan—CYP2A6—cerebellum—brain cancer	0.000377	0.00327	CbGeAlD
Eletriptan—ABCB1—blood vessel—brain cancer	0.000377	0.00326	CbGeAlD
Eletriptan—HTR7—gonad—brain cancer	0.000373	0.00323	CbGeAlD
Eletriptan—HTR1B—endocrine gland—brain cancer	0.000366	0.00317	CbGeAlD
Eletriptan—HTR1B—head—brain cancer	0.000361	0.00313	CbGeAlD
Eletriptan—Hallucination—Hydroxyurea—brain cancer	0.000352	0.00281	CcSEcCtD
Eletriptan—HTR7—medulla oblongata—brain cancer	0.000351	0.00305	CbGeAlD
Eletriptan—Loss of consciousness—Procarbazine—brain cancer	0.00035	0.00279	CcSEcCtD
Eletriptan—HTR1D—head—brain cancer	0.000349	0.00303	CbGeAlD
Eletriptan—Abdominal distension—Temozolomide—brain cancer	0.000348	0.00278	CcSEcCtD
Eletriptan—Cough—Procarbazine—brain cancer	0.000348	0.00277	CcSEcCtD
Eletriptan—Dysphagia—Temozolomide—brain cancer	0.000346	0.00276	CcSEcCtD
Eletriptan—Convulsion—Procarbazine—brain cancer	0.000345	0.00275	CcSEcCtD
Eletriptan—Hypertension—Procarbazine—brain cancer	0.000344	0.00274	CcSEcCtD
Eletriptan—Arthralgia—Procarbazine—brain cancer	0.000339	0.00271	CcSEcCtD
Eletriptan—Myalgia—Procarbazine—brain cancer	0.000339	0.00271	CcSEcCtD
Eletriptan—Anxiety—Procarbazine—brain cancer	0.000338	0.0027	CcSEcCtD
Eletriptan—HTR1A—midbrain—brain cancer	0.000336	0.00291	CbGeAlD
Eletriptan—Bronchitis—Temozolomide—brain cancer	0.000332	0.00265	CcSEcCtD
Eletriptan—Dry mouth—Procarbazine—brain cancer	0.000332	0.00265	CcSEcCtD
Eletriptan—HTR1B—central nervous system—brain cancer	0.000329	0.00286	CbGeAlD
Eletriptan—Confusional state—Procarbazine—brain cancer	0.000328	0.00262	CcSEcCtD
Eletriptan—HTR1A—spinal cord—brain cancer	0.000328	0.00284	CbGeAlD
Eletriptan—Vomiting—Lomustine—brain cancer	0.000326	0.0026	CcSEcCtD
Eletriptan—Oedema—Procarbazine—brain cancer	0.000325	0.00259	CcSEcCtD
Eletriptan—HTR2B—head—brain cancer	0.000325	0.00282	CbGeAlD
Eletriptan—Hyperglycaemia—Carmustine—brain cancer	0.000323	0.00257	CcSEcCtD
Eletriptan—HTR7—midbrain—brain cancer	0.000321	0.00278	CbGeAlD
Eletriptan—Shock—Procarbazine—brain cancer	0.00032	0.00255	CcSEcCtD
Eletriptan—Pollakiuria—Temozolomide—brain cancer	0.000319	0.00255	CcSEcCtD
Eletriptan—HTR1D—central nervous system—brain cancer	0.000319	0.00277	CbGeAlD
Eletriptan—Erectile dysfunction—Temozolomide—brain cancer	0.000318	0.00254	CcSEcCtD
Eletriptan—Chills—Hydroxyurea—brain cancer	0.000318	0.00254	CcSEcCtD
Eletriptan—Tachycardia—Procarbazine—brain cancer	0.000317	0.00253	CcSEcCtD
Eletriptan—Weight increased—Temozolomide—brain cancer	0.000315	0.00251	CcSEcCtD
Eletriptan—Hyperhidrosis—Procarbazine—brain cancer	0.000314	0.00251	CcSEcCtD
Eletriptan—HTR7—spinal cord—brain cancer	0.000313	0.00272	CbGeAlD
Eletriptan—Alopecia—Hydroxyurea—brain cancer	0.000313	0.0025	CcSEcCtD
Eletriptan—Weight decreased—Temozolomide—brain cancer	0.000313	0.0025	CcSEcCtD
Eletriptan—Neuropathy peripheral—Carmustine—brain cancer	0.000313	0.00249	CcSEcCtD
Eletriptan—Hyperglycaemia—Temozolomide—brain cancer	0.000312	0.00249	CcSEcCtD
Eletriptan—Stomatitis—Carmustine—brain cancer	0.000311	0.00248	CcSEcCtD
Eletriptan—Anorexia—Procarbazine—brain cancer	0.00031	0.00247	CcSEcCtD
Eletriptan—PTGS1—telencephalon—brain cancer	0.000309	0.00268	CbGeAlD
Eletriptan—CYP2A6—brain—brain cancer	0.000306	0.00266	CbGeAlD
Eletriptan—Nausea—Lomustine—brain cancer	0.000304	0.00243	CcSEcCtD
Eletriptan—Hypotension—Procarbazine—brain cancer	0.000304	0.00242	CcSEcCtD
Eletriptan—Neuropathy peripheral—Temozolomide—brain cancer	0.000302	0.00241	CcSEcCtD
Eletriptan—Stomatitis—Temozolomide—brain cancer	0.0003	0.0024	CcSEcCtD
Eletriptan—HTR2B—central nervous system—brain cancer	0.000297	0.00257	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000296	0.00236	CcSEcCtD
Eletriptan—HTR1A—endocrine gland—brain cancer	0.000295	0.00256	CbGeAlD
Eletriptan—Insomnia—Procarbazine—brain cancer	0.000294	0.00235	CcSEcCtD
Eletriptan—Paraesthesia—Procarbazine—brain cancer	0.000292	0.00233	CcSEcCtD
Eletriptan—HTR1A—head—brain cancer	0.000291	0.00253	CbGeAlD
Eletriptan—Sinusitis—Temozolomide—brain cancer	0.000289	0.00231	CcSEcCtD
Eletriptan—Somnolence—Procarbazine—brain cancer	0.000289	0.00231	CcSEcCtD
Eletriptan—Cramp muscle—Etoposide—brain cancer	0.000288	0.0023	CcSEcCtD
Eletriptan—CYP2D6—brainstem—brain cancer	0.000286	0.00248	CbGeAlD
Eletriptan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000286	0.00228	CcSEcCtD
Eletriptan—Anaemia—Hydroxyurea—brain cancer	0.000285	0.00227	CcSEcCtD
Eletriptan—Hallucination—Carmustine—brain cancer	0.000285	0.00227	CcSEcCtD
Eletriptan—Hypoaesthesia—Carmustine—brain cancer	0.000285	0.00227	CcSEcCtD
Eletriptan—Decreased appetite—Procarbazine—brain cancer	0.000283	0.00226	CcSEcCtD
Eletriptan—Oedema peripheral—Carmustine—brain cancer	0.000282	0.00225	CcSEcCtD
Eletriptan—HTR7—endocrine gland—brain cancer	0.000282	0.00244	CbGeAlD
Eletriptan—Fatigue—Procarbazine—brain cancer	0.00028	0.00224	CcSEcCtD
Eletriptan—HTR7—head—brain cancer	0.000278	0.00241	CbGeAlD
Eletriptan—Malaise—Hydroxyurea—brain cancer	0.000278	0.00222	CcSEcCtD
Eletriptan—Pain—Procarbazine—brain cancer	0.000278	0.00222	CcSEcCtD
Eletriptan—Constipation—Procarbazine—brain cancer	0.000278	0.00222	CcSEcCtD
Eletriptan—Dysphagia—Etoposide—brain cancer	0.000277	0.00221	CcSEcCtD
Eletriptan—Leukopenia—Hydroxyurea—brain cancer	0.000276	0.0022	CcSEcCtD
Eletriptan—Visual impairment—Carmustine—brain cancer	0.000276	0.0022	CcSEcCtD
Eletriptan—CYP2C19—endocrine gland—brain cancer	0.000275	0.00239	CbGeAlD
Eletriptan—Hypoaesthesia—Temozolomide—brain cancer	0.000275	0.0022	CcSEcCtD
Eletriptan—Hallucination—Temozolomide—brain cancer	0.000275	0.0022	CcSEcCtD
Eletriptan—Pharyngitis—Temozolomide—brain cancer	0.000275	0.00219	CcSEcCtD
Eletriptan—Urinary tract disorder—Temozolomide—brain cancer	0.000273	0.00218	CcSEcCtD
Eletriptan—Oedema peripheral—Temozolomide—brain cancer	0.000273	0.00217	CcSEcCtD
Eletriptan—Urethral disorder—Temozolomide—brain cancer	0.000271	0.00216	CcSEcCtD
Eletriptan—Feeling abnormal—Procarbazine—brain cancer	0.000268	0.00214	CcSEcCtD
Eletriptan—Convulsion—Hydroxyurea—brain cancer	0.000267	0.00213	CcSEcCtD
Eletriptan—Visual impairment—Temozolomide—brain cancer	0.000267	0.00213	CcSEcCtD
Eletriptan—Gastrointestinal pain—Procarbazine—brain cancer	0.000266	0.00212	CcSEcCtD
Eletriptan—HTR1A—central nervous system—brain cancer	0.000266	0.00231	CbGeAlD
Eletriptan—Flushing—Carmustine—brain cancer	0.000266	0.00212	CcSEcCtD
Eletriptan—HTR1B—brain—brain cancer	0.000262	0.00227	CbGeAlD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000261	0.00208	CcSEcCtD
Eletriptan—HTR1A—cerebellum—brain cancer	0.00026	0.00225	CbGeAlD
Eletriptan—Discomfort—Hydroxyurea—brain cancer	0.000259	0.00207	CcSEcCtD
Eletriptan—Urticaria—Procarbazine—brain cancer	0.000258	0.00206	CcSEcCtD
Eletriptan—Tinnitus—Temozolomide—brain cancer	0.000258	0.00206	CcSEcCtD
Eletriptan—Body temperature increased—Procarbazine—brain cancer	0.000257	0.00205	CcSEcCtD
Eletriptan—Abdominal pain—Procarbazine—brain cancer	0.000257	0.00205	CcSEcCtD
Eletriptan—Flushing—Temozolomide—brain cancer	0.000257	0.00205	CcSEcCtD
Eletriptan—Arrhythmia—Carmustine—brain cancer	0.000256	0.00204	CcSEcCtD
Eletriptan—HTR7—central nervous system—brain cancer	0.000254	0.0022	CbGeAlD
Eletriptan—CYP2D6—telencephalon—brain cancer	0.000254	0.0022	CbGeAlD
Eletriptan—HTR1D—brain—brain cancer	0.000253	0.0022	CbGeAlD
Eletriptan—Alopecia—Carmustine—brain cancer	0.000253	0.00202	CcSEcCtD
Eletriptan—Oedema—Hydroxyurea—brain cancer	0.000252	0.00201	CcSEcCtD
Eletriptan—PTGS1—pituitary gland—brain cancer	0.000252	0.00218	CbGeAlD
Eletriptan—Immune system disorder—Temozolomide—brain cancer	0.00025	0.00199	CcSEcCtD
Eletriptan—HTR7—cerebellum—brain cancer	0.000248	0.00215	CbGeAlD
Eletriptan—Chills—Temozolomide—brain cancer	0.000248	0.00198	CcSEcCtD
Eletriptan—Nervous system disorder—Hydroxyurea—brain cancer	0.000247	0.00197	CcSEcCtD
Eletriptan—Alopecia—Temozolomide—brain cancer	0.000245	0.00195	CcSEcCtD
Eletriptan—Skin disorder—Hydroxyurea—brain cancer	0.000244	0.00195	CcSEcCtD
Eletriptan—Acute coronary syndrome—Etoposide—brain cancer	0.000243	0.00194	CcSEcCtD
Eletriptan—Neuropathy peripheral—Etoposide—brain cancer	0.000242	0.00193	CcSEcCtD
Eletriptan—Myocardial infarction—Etoposide—brain cancer	0.000242	0.00193	CcSEcCtD
Eletriptan—Back pain—Carmustine—brain cancer	0.000241	0.00192	CcSEcCtD
Eletriptan—Stomatitis—Etoposide—brain cancer	0.00024	0.00192	CcSEcCtD
Eletriptan—Anorexia—Hydroxyurea—brain cancer	0.00024	0.00191	CcSEcCtD
Eletriptan—Hypersensitivity—Procarbazine—brain cancer	0.00024	0.00191	CcSEcCtD
Eletriptan—Dysgeusia—Temozolomide—brain cancer	0.000236	0.00188	CcSEcCtD
Eletriptan—HTR2B—brain—brain cancer	0.000236	0.00204	CbGeAlD
Eletriptan—Tremor—Carmustine—brain cancer	0.000234	0.00186	CcSEcCtD
Eletriptan—Asthenia—Procarbazine—brain cancer	0.000233	0.00186	CcSEcCtD
Eletriptan—Back pain—Temozolomide—brain cancer	0.000233	0.00186	CcSEcCtD
Eletriptan—Anaemia—Carmustine—brain cancer	0.00023	0.00184	CcSEcCtD
Eletriptan—Pruritus—Procarbazine—brain cancer	0.00023	0.00184	CcSEcCtD
Eletriptan—Agitation—Carmustine—brain cancer	0.000229	0.00183	CcSEcCtD
Eletriptan—Tremor—Temozolomide—brain cancer	0.000226	0.0018	CcSEcCtD
Eletriptan—Dyspnoea—Hydroxyurea—brain cancer	0.000224	0.00179	CcSEcCtD
Eletriptan—Somnolence—Hydroxyurea—brain cancer	0.000224	0.00178	CcSEcCtD
Eletriptan—Ill-defined disorder—Temozolomide—brain cancer	0.000224	0.00178	CcSEcCtD
Eletriptan—Leukopenia—Carmustine—brain cancer	0.000223	0.00178	CcSEcCtD
Eletriptan—Anaemia—Temozolomide—brain cancer	0.000223	0.00178	CcSEcCtD
Eletriptan—Diarrhoea—Procarbazine—brain cancer	0.000222	0.00178	CcSEcCtD
Eletriptan—Dyspepsia—Hydroxyurea—brain cancer	0.000222	0.00177	CcSEcCtD
Eletriptan—Agitation—Temozolomide—brain cancer	0.000221	0.00177	CcSEcCtD
Eletriptan—Hypoaesthesia—Etoposide—brain cancer	0.00022	0.00176	CcSEcCtD
Eletriptan—Angioedema—Temozolomide—brain cancer	0.00022	0.00176	CcSEcCtD
Eletriptan—Decreased appetite—Hydroxyurea—brain cancer	0.000219	0.00175	CcSEcCtD
Eletriptan—Urinary tract disorder—Etoposide—brain cancer	0.000219	0.00174	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000217	0.00173	CcSEcCtD
Eletriptan—Malaise—Temozolomide—brain cancer	0.000217	0.00173	CcSEcCtD
Eletriptan—Urethral disorder—Etoposide—brain cancer	0.000217	0.00173	CcSEcCtD
Eletriptan—Fatigue—Hydroxyurea—brain cancer	0.000217	0.00173	CcSEcCtD
Eletriptan—PTGS1—spinal cord—brain cancer	0.000217	0.00188	CbGeAlD
Eletriptan—Vertigo—Temozolomide—brain cancer	0.000216	0.00173	CcSEcCtD
Eletriptan—Convulsion—Carmustine—brain cancer	0.000216	0.00172	CcSEcCtD
Eletriptan—Leukopenia—Temozolomide—brain cancer	0.000216	0.00172	CcSEcCtD
Eletriptan—Hypertension—Carmustine—brain cancer	0.000215	0.00172	CcSEcCtD
Eletriptan—Pain—Hydroxyurea—brain cancer	0.000215	0.00172	CcSEcCtD
Eletriptan—Constipation—Hydroxyurea—brain cancer	0.000215	0.00172	CcSEcCtD
Eletriptan—Dizziness—Procarbazine—brain cancer	0.000215	0.00172	CcSEcCtD
Eletriptan—CYP2C9—endocrine gland—brain cancer	0.000213	0.00185	CbGeAlD
Eletriptan—Palpitations—Temozolomide—brain cancer	0.000213	0.0017	CcSEcCtD
Eletriptan—Myalgia—Carmustine—brain cancer	0.000212	0.00169	CcSEcCtD
Eletriptan—Anxiety—Carmustine—brain cancer	0.000211	0.00169	CcSEcCtD
Eletriptan—HTR1A—brain—brain cancer	0.000211	0.00183	CbGeAlD
Eletriptan—Cough—Temozolomide—brain cancer	0.00021	0.00168	CcSEcCtD
Eletriptan—Convulsion—Temozolomide—brain cancer	0.000209	0.00167	CcSEcCtD
Eletriptan—Hypertension—Temozolomide—brain cancer	0.000208	0.00166	CcSEcCtD
Eletriptan—Feeling abnormal—Hydroxyurea—brain cancer	0.000207	0.00165	CcSEcCtD
Eletriptan—Vomiting—Procarbazine—brain cancer	0.000207	0.00165	CcSEcCtD
Eletriptan—Flushing—Etoposide—brain cancer	0.000206	0.00164	CcSEcCtD
Eletriptan—Confusional state—Carmustine—brain cancer	0.000205	0.00164	CcSEcCtD
Eletriptan—Arthralgia—Temozolomide—brain cancer	0.000205	0.00164	CcSEcCtD
Eletriptan—Myalgia—Temozolomide—brain cancer	0.000205	0.00164	CcSEcCtD
Eletriptan—Rash—Procarbazine—brain cancer	0.000205	0.00164	CcSEcCtD
Eletriptan—Dermatitis—Procarbazine—brain cancer	0.000205	0.00163	CcSEcCtD
Eletriptan—Anxiety—Temozolomide—brain cancer	0.000204	0.00163	CcSEcCtD
Eletriptan—Headache—Procarbazine—brain cancer	0.000204	0.00163	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000204	0.00162	CcSEcCtD
Eletriptan—Oedema—Carmustine—brain cancer	0.000203	0.00162	CcSEcCtD
Eletriptan—Discomfort—Temozolomide—brain cancer	0.000203	0.00162	CcSEcCtD
Eletriptan—HTR7—brain—brain cancer	0.000202	0.00175	CbGeAlD
Eletriptan—Dry mouth—Temozolomide—brain cancer	0.000201	0.0016	CcSEcCtD
Eletriptan—Immune system disorder—Etoposide—brain cancer	0.0002	0.0016	CcSEcCtD
Eletriptan—Body temperature increased—Hydroxyurea—brain cancer	0.000199	0.00159	CcSEcCtD
Eletriptan—Chills—Etoposide—brain cancer	0.000199	0.00159	CcSEcCtD
Eletriptan—Tachycardia—Carmustine—brain cancer	0.000199	0.00158	CcSEcCtD
Eletriptan—Confusional state—Temozolomide—brain cancer	0.000198	0.00158	CcSEcCtD
Eletriptan—Oedema—Temozolomide—brain cancer	0.000197	0.00157	CcSEcCtD
Eletriptan—Alopecia—Etoposide—brain cancer	0.000196	0.00156	CcSEcCtD
Eletriptan—PTGS1—endocrine gland—brain cancer	0.000195	0.00169	CbGeAlD
Eletriptan—Anorexia—Carmustine—brain cancer	0.000194	0.00155	CcSEcCtD
Eletriptan—Nausea—Procarbazine—brain cancer	0.000193	0.00154	CcSEcCtD
Eletriptan—Nervous system disorder—Temozolomide—brain cancer	0.000193	0.00154	CcSEcCtD
Eletriptan—PTGS1—head—brain cancer	0.000192	0.00167	CbGeAlD
Eletriptan—Skin disorder—Temozolomide—brain cancer	0.000191	0.00152	CcSEcCtD
Eletriptan—Hypotension—Carmustine—brain cancer	0.00019	0.00152	CcSEcCtD
Eletriptan—Hyperhidrosis—Temozolomide—brain cancer	0.00019	0.00152	CcSEcCtD
Eletriptan—Dysgeusia—Etoposide—brain cancer	0.000189	0.00151	CcSEcCtD
Eletriptan—Anorexia—Temozolomide—brain cancer	0.000187	0.0015	CcSEcCtD
Eletriptan—Back pain—Etoposide—brain cancer	0.000186	0.00149	CcSEcCtD
Eletriptan—Hypersensitivity—Hydroxyurea—brain cancer	0.000185	0.00148	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Carmustine—brain cancer	0.000185	0.00148	CcSEcCtD
Eletriptan—Muscle spasms—Etoposide—brain cancer	0.000185	0.00148	CcSEcCtD
Eletriptan—Insomnia—Carmustine—brain cancer	0.000184	0.00147	CcSEcCtD
Eletriptan—ABCB1—telencephalon—brain cancer	0.000183	0.00158	CbGeAlD
Eletriptan—Paraesthesia—Carmustine—brain cancer	0.000183	0.00146	CcSEcCtD
Eletriptan—Dyspnoea—Carmustine—brain cancer	0.000181	0.00145	CcSEcCtD
Eletriptan—Somnolence—Carmustine—brain cancer	0.000181	0.00144	CcSEcCtD
Eletriptan—Asthenia—Hydroxyurea—brain cancer	0.000181	0.00144	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000179	0.00143	CcSEcCtD
Eletriptan—Ill-defined disorder—Etoposide—brain cancer	0.000179	0.00143	CcSEcCtD
Eletriptan—Anaemia—Etoposide—brain cancer	0.000178	0.00142	CcSEcCtD
Eletriptan—Insomnia—Temozolomide—brain cancer	0.000178	0.00142	CcSEcCtD
Eletriptan—Decreased appetite—Carmustine—brain cancer	0.000177	0.00141	CcSEcCtD
Eletriptan—Paraesthesia—Temozolomide—brain cancer	0.000177	0.00141	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Carmustine—brain cancer	0.000176	0.0014	CcSEcCtD
Eletriptan—PTGS1—central nervous system—brain cancer	0.000176	0.00152	CbGeAlD
Eletriptan—Dyspnoea—Temozolomide—brain cancer	0.000175	0.0014	CcSEcCtD
Eletriptan—Somnolence—Temozolomide—brain cancer	0.000175	0.00139	CcSEcCtD
Eletriptan—Pain—Carmustine—brain cancer	0.000174	0.00139	CcSEcCtD
Eletriptan—Constipation—Carmustine—brain cancer	0.000174	0.00139	CcSEcCtD
Eletriptan—Malaise—Etoposide—brain cancer	0.000174	0.00139	CcSEcCtD
Eletriptan—Vertigo—Etoposide—brain cancer	0.000173	0.00138	CcSEcCtD
Eletriptan—Dyspepsia—Temozolomide—brain cancer	0.000173	0.00138	CcSEcCtD
Eletriptan—Leukopenia—Etoposide—brain cancer	0.000173	0.00138	CcSEcCtD
Eletriptan—Diarrhoea—Hydroxyurea—brain cancer	0.000172	0.00137	CcSEcCtD
Eletriptan—Decreased appetite—Temozolomide—brain cancer	0.000171	0.00136	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Temozolomide—brain cancer	0.00017	0.00135	CcSEcCtD
Eletriptan—Fatigue—Temozolomide—brain cancer	0.00017	0.00135	CcSEcCtD
Eletriptan—Loss of consciousness—Etoposide—brain cancer	0.000169	0.00135	CcSEcCtD
Eletriptan—Cough—Etoposide—brain cancer	0.000168	0.00134	CcSEcCtD
Eletriptan—Pain—Temozolomide—brain cancer	0.000168	0.00134	CcSEcCtD
Eletriptan—Constipation—Temozolomide—brain cancer	0.000168	0.00134	CcSEcCtD
Eletriptan—Feeling abnormal—Carmustine—brain cancer	0.000168	0.00134	CcSEcCtD
Eletriptan—Convulsion—Etoposide—brain cancer	0.000167	0.00133	CcSEcCtD
Eletriptan—Hypertension—Etoposide—brain cancer	0.000166	0.00133	CcSEcCtD
Eletriptan—Dizziness—Hydroxyurea—brain cancer	0.000166	0.00133	CcSEcCtD
Eletriptan—Gastrointestinal pain—Carmustine—brain cancer	0.000166	0.00133	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000163	0.0013	CcSEcCtD
Eletriptan—CYP3A4—endocrine gland—brain cancer	0.000163	0.00141	CbGeAlD
Eletriptan—Discomfort—Etoposide—brain cancer	0.000162	0.00129	CcSEcCtD
Eletriptan—Feeling abnormal—Temozolomide—brain cancer	0.000162	0.00129	CcSEcCtD
Eletriptan—Body temperature increased—Carmustine—brain cancer	0.000161	0.00128	CcSEcCtD
Eletriptan—Abdominal pain—Carmustine—brain cancer	0.000161	0.00128	CcSEcCtD
Eletriptan—Gastrointestinal pain—Temozolomide—brain cancer	0.000161	0.00128	CcSEcCtD
Eletriptan—CYP2D6—endocrine gland—brain cancer	0.00016	0.00139	CbGeAlD
Eletriptan—Vomiting—Hydroxyurea—brain cancer	0.00016	0.00128	CcSEcCtD
Eletriptan—Rash—Hydroxyurea—brain cancer	0.000159	0.00127	CcSEcCtD
Eletriptan—Confusional state—Etoposide—brain cancer	0.000159	0.00127	CcSEcCtD
Eletriptan—Dermatitis—Hydroxyurea—brain cancer	0.000159	0.00126	CcSEcCtD
Eletriptan—CYP2D6—head—brain cancer	0.000158	0.00137	CbGeAlD
Eletriptan—Headache—Hydroxyurea—brain cancer	0.000158	0.00126	CcSEcCtD
Eletriptan—Urticaria—Temozolomide—brain cancer	0.000156	0.00125	CcSEcCtD
Eletriptan—Body temperature increased—Temozolomide—brain cancer	0.000155	0.00124	CcSEcCtD
Eletriptan—Abdominal pain—Temozolomide—brain cancer	0.000155	0.00124	CcSEcCtD
Eletriptan—Tachycardia—Etoposide—brain cancer	0.000154	0.00122	CcSEcCtD
Eletriptan—Skin disorder—Etoposide—brain cancer	0.000153	0.00122	CcSEcCtD
Eletriptan—ABCB1—gonad—brain cancer	0.000152	0.00132	CbGeAlD
Eletriptan—Hyperhidrosis—Etoposide—brain cancer	0.000152	0.00121	CcSEcCtD
Eletriptan—Anorexia—Etoposide—brain cancer	0.00015	0.0012	CcSEcCtD
Eletriptan—Hypersensitivity—Carmustine—brain cancer	0.00015	0.0012	CcSEcCtD
Eletriptan—Nausea—Hydroxyurea—brain cancer	0.000149	0.00119	CcSEcCtD
Eletriptan—ABCB1—pituitary gland—brain cancer	0.000149	0.00129	CbGeAlD
Eletriptan—Hypotension—Etoposide—brain cancer	0.000147	0.00117	CcSEcCtD
Eletriptan—CYP3A4—central nervous system—brain cancer	0.000147	0.00127	CbGeAlD
Eletriptan—Asthenia—Carmustine—brain cancer	0.000146	0.00116	CcSEcCtD
Eletriptan—Hypersensitivity—Temozolomide—brain cancer	0.000145	0.00116	CcSEcCtD
Eletriptan—CYP2D6—central nervous system—brain cancer	0.000144	0.00125	CbGeAlD
Eletriptan—ABCB1—medulla oblongata—brain cancer	0.000144	0.00124	CbGeAlD
Eletriptan—Paraesthesia—Etoposide—brain cancer	0.000141	0.00113	CcSEcCtD
Eletriptan—CYP2D6—cerebellum—brain cancer	0.000141	0.00122	CbGeAlD
Eletriptan—Asthenia—Temozolomide—brain cancer	0.000141	0.00113	CcSEcCtD
Eletriptan—Dyspnoea—Etoposide—brain cancer	0.00014	0.00112	CcSEcCtD
Eletriptan—Somnolence—Etoposide—brain cancer	0.00014	0.00112	CcSEcCtD
Eletriptan—PTGS1—brain—brain cancer	0.000139	0.00121	CbGeAlD
Eletriptan—Diarrhoea—Carmustine—brain cancer	0.000139	0.00111	CcSEcCtD
Eletriptan—Pruritus—Temozolomide—brain cancer	0.000139	0.00111	CcSEcCtD
Eletriptan—Decreased appetite—Etoposide—brain cancer	0.000137	0.00109	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Etoposide—brain cancer	0.000136	0.00108	CcSEcCtD
Eletriptan—Fatigue—Etoposide—brain cancer	0.000136	0.00108	CcSEcCtD
Eletriptan—Dizziness—Carmustine—brain cancer	0.000135	0.00107	CcSEcCtD
Eletriptan—Pain—Etoposide—brain cancer	0.000135	0.00107	CcSEcCtD
Eletriptan—Constipation—Etoposide—brain cancer	0.000135	0.00107	CcSEcCtD
Eletriptan—Diarrhoea—Temozolomide—brain cancer	0.000135	0.00107	CcSEcCtD
Eletriptan—ABCB1—midbrain—brain cancer	0.000131	0.00114	CbGeAlD
Eletriptan—Dizziness—Temozolomide—brain cancer	0.00013	0.00104	CcSEcCtD
Eletriptan—Feeling abnormal—Etoposide—brain cancer	0.00013	0.00103	CcSEcCtD
Eletriptan—Vomiting—Carmustine—brain cancer	0.000129	0.00103	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etoposide—brain cancer	0.000129	0.00103	CcSEcCtD
Eletriptan—Rash—Carmustine—brain cancer	0.000128	0.00102	CcSEcCtD
Eletriptan—Dermatitis—Carmustine—brain cancer	0.000128	0.00102	CcSEcCtD
Eletriptan—ABCB1—spinal cord—brain cancer	0.000128	0.00111	CbGeAlD
Eletriptan—Headache—Carmustine—brain cancer	0.000127	0.00102	CcSEcCtD
Eletriptan—Vomiting—Temozolomide—brain cancer	0.000125	0.000997	CcSEcCtD
Eletriptan—Urticaria—Etoposide—brain cancer	0.000125	0.000997	CcSEcCtD
Eletriptan—Body temperature increased—Etoposide—brain cancer	0.000124	0.000992	CcSEcCtD
Eletriptan—Abdominal pain—Etoposide—brain cancer	0.000124	0.000992	CcSEcCtD
Eletriptan—Rash—Temozolomide—brain cancer	0.000124	0.000989	CcSEcCtD
Eletriptan—Dermatitis—Temozolomide—brain cancer	0.000124	0.000988	CcSEcCtD
Eletriptan—Headache—Temozolomide—brain cancer	0.000123	0.000983	CcSEcCtD
Eletriptan—Nausea—Carmustine—brain cancer	0.000121	0.000964	CcSEcCtD
Eletriptan—Nausea—Temozolomide—brain cancer	0.000117	0.000932	CcSEcCtD
Eletriptan—Hypersensitivity—Etoposide—brain cancer	0.000116	0.000925	CcSEcCtD
Eletriptan—ABCB1—endocrine gland—brain cancer	0.000115	0.000999	CbGeAlD
Eletriptan—CYP2D6—brain—brain cancer	0.000115	0.000994	CbGeAlD
Eletriptan—ABCB1—head—brain cancer	0.000114	0.000986	CbGeAlD
Eletriptan—Asthenia—Etoposide—brain cancer	0.000113	0.000901	CcSEcCtD
Eletriptan—Pruritus—Etoposide—brain cancer	0.000111	0.000888	CcSEcCtD
Eletriptan—Diarrhoea—Etoposide—brain cancer	0.000108	0.000859	CcSEcCtD
Eletriptan—Dizziness—Etoposide—brain cancer	0.000104	0.00083	CcSEcCtD
Eletriptan—ABCB1—central nervous system—brain cancer	0.000104	0.0009	CbGeAlD
Eletriptan—ABCB1—cerebellum—brain cancer	0.000101	0.00088	CbGeAlD
Eletriptan—Vomiting—Etoposide—brain cancer	0.0001	0.000798	CcSEcCtD
Eletriptan—Rash—Etoposide—brain cancer	9.92e-05	0.000791	CcSEcCtD
Eletriptan—Dermatitis—Etoposide—brain cancer	9.91e-05	0.000791	CcSEcCtD
Eletriptan—Headache—Etoposide—brain cancer	9.86e-05	0.000786	CcSEcCtD
Eletriptan—Nausea—Etoposide—brain cancer	9.34e-05	0.000746	CcSEcCtD
Eletriptan—ABCB1—brain—brain cancer	8.24e-05	0.000715	CbGeAlD
Eletriptan—HTR2B—GPCR downstream signaling—VAV1—brain cancer	2.37e-05	0.000657	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GFAP—brain cancer	2.37e-05	0.000657	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—VAV1—brain cancer	2.36e-05	0.000653	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—VAV1—brain cancer	2.34e-05	0.000649	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TRPC6—brain cancer	2.33e-05	0.000646	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PIK3CG—brain cancer	2.32e-05	0.000644	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HEY1—brain cancer	2.31e-05	0.000641	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SUFU—brain cancer	2.31e-05	0.00064	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HEY1—brain cancer	2.3e-05	0.000636	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—BSG—brain cancer	2.29e-05	0.000636	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—VAV1—brain cancer	2.29e-05	0.000636	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SMO—brain cancer	2.29e-05	0.000635	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTCH1—brain cancer	2.29e-05	0.000635	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.29e-05	0.000635	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOTCH2—brain cancer	2.27e-05	0.000629	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DLL1—brain cancer	2.27e-05	0.000628	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DLL1—brain cancer	2.25e-05	0.000624	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HEY1—brain cancer	2.25e-05	0.000623	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GFAP—brain cancer	2.23e-05	0.000618	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DLL1—brain cancer	2.2e-05	0.000611	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PIK3CG—brain cancer	2.19e-05	0.000608	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ABR—brain cancer	2.17e-05	0.000603	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VAV1—brain cancer	2.16e-05	0.0006	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—VAV1—brain cancer	2.15e-05	0.000597	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOTCH2—brain cancer	2.14e-05	0.000593	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HEY1—brain cancer	2.11e-05	0.000585	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GLI2—brain cancer	2.1e-05	0.000582	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—IDH1—brain cancer	2.09e-05	0.000578	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DLL1—brain cancer	2.07e-05	0.000574	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VAV1—brain cancer	2.04e-05	0.000566	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GLI1—brain cancer	1.97e-05	0.000548	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—IDH1—brain cancer	1.97e-05	0.000547	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SHH—brain cancer	1.93e-05	0.000534	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—VAV1—brain cancer	1.92e-05	0.000533	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SHH—brain cancer	1.91e-05	0.000531	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.91e-05	0.00053	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SHH—brain cancer	1.87e-05	0.00052	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SUFU—brain cancer	1.87e-05	0.000519	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HES1—brain cancer	1.86e-05	0.000516	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TRPC6—brain cancer	1.86e-05	0.000515	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TRPC6—brain cancer	1.85e-05	0.000512	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTCH1—brain cancer	1.83e-05	0.000506	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SMO—brain cancer	1.83e-05	0.000506	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTCH1—brain cancer	1.81e-05	0.000503	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SMO—brain cancer	1.81e-05	0.000503	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TRPC6—brain cancer	1.81e-05	0.000501	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GFAP—brain cancer	1.81e-05	0.000501	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—IL2—brain cancer	1.8e-05	0.000499	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.78e-05	0.000493	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SMO—brain cancer	1.78e-05	0.000493	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTCH1—brain cancer	1.78e-05	0.000493	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PDGFRA—brain cancer	1.77e-05	0.000491	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SHH—brain cancer	1.76e-05	0.000488	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HES1—brain cancer	1.75e-05	0.000486	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—VAV1—brain cancer	1.75e-05	0.000484	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SPP1—brain cancer	1.72e-05	0.000477	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HEY1—brain cancer	1.71e-05	0.000475	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—IL2—brain cancer	1.7e-05	0.000471	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.7e-05	0.000471	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TRPC6—brain cancer	1.7e-05	0.000471	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DLL1—brain cancer	1.68e-05	0.000466	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PDGFRA—brain cancer	1.67e-05	0.000463	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTCH1—brain cancer	1.67e-05	0.000463	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SMO—brain cancer	1.67e-05	0.000463	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ENO2—brain cancer	1.65e-05	0.000457	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PIK3CG—brain cancer	1.65e-05	0.000457	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000456	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PIK3CG—brain cancer	1.64e-05	0.000454	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL2—brain cancer	1.64e-05	0.000453	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SPP1—brain cancer	1.62e-05	0.00045	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2C9—brain cancer	1.61e-05	0.000445	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	1.6e-05	0.000444	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.57e-05	0.000435	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ENO2—brain cancer	1.56e-05	0.000432	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.55e-05	0.000431	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IRS2—brain cancer	1.55e-05	0.000431	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL2—brain cancer	1.54e-05	0.000428	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000419	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	1.51e-05	0.000417	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PIK3CG—brain cancer	1.5e-05	0.000415	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PIK3CG—brain cancer	1.49e-05	0.000412	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IRS2—brain cancer	1.47e-05	0.000407	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOTCH2—brain cancer	1.46e-05	0.000405	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	1.46e-05	0.000404	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOTCH2—brain cancer	1.45e-05	0.000402	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SHH—brain cancer	1.43e-05	0.000396	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOTCH2—brain cancer	1.42e-05	0.000394	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—BSG—brain cancer	1.4e-05	0.000388	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VAV1—brain cancer	1.39e-05	0.000386	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VAV1—brain cancer	1.38e-05	0.000383	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TRPC6—brain cancer	1.38e-05	0.000382	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PIK3CG—brain cancer	1.37e-05	0.000381	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—APC—brain cancer	1.37e-05	0.000381	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.37e-05	0.00038	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	1.37e-05	0.000379	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—BSG—brain cancer	1.36e-05	0.000379	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VAV1—brain cancer	1.35e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTCH1—brain cancer	1.35e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SMO—brain cancer	1.35e-05	0.000375	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.33e-05	0.00037	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—APC—brain cancer	1.3e-05	0.000359	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PIK3CG—brain cancer	1.3e-05	0.000359	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BSG—brain cancer	1.29e-05	0.000357	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BSG—brain cancer	1.28e-05	0.000354	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VAV1—brain cancer	1.27e-05	0.000353	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.26e-05	0.000349	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—brain cancer	1.25e-05	0.000347	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.23e-05	0.000342	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	1.22e-05	0.000339	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—IDH1—brain cancer	1.2e-05	0.000333	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HES1—brain cancer	1.2e-05	0.000332	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HES1—brain cancer	1.19e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—brain cancer	1.18e-05	0.000327	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—IDH1—brain cancer	1.17e-05	0.000325	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HES1—brain cancer	1.16e-05	0.000323	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL2—brain cancer	1.16e-05	0.000321	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL2—brain cancer	1.15e-05	0.000319	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PDGFRA—brain cancer	1.14e-05	0.000316	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PDGFRA—brain cancer	1.13e-05	0.000314	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL2—brain cancer	1.13e-05	0.000313	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PDGFRA—brain cancer	1.11e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.11e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPP1—brain cancer	1.11e-05	0.000307	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—IDH1—brain cancer	1.11e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPP1—brain cancer	1.1e-05	0.000305	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—IDH1—brain cancer	1.1e-05	0.000304	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HES1—brain cancer	1.09e-05	0.000303	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.08e-05	0.0003	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPP1—brain cancer	1.08e-05	0.000298	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RELA—brain cancer	1.07e-05	0.000297	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ERBB2—brain cancer	1.07e-05	0.000296	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.06e-05	0.000294	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL2—brain cancer	1.05e-05	0.000292	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL2—brain cancer	1.05e-05	0.00029	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.04e-05	0.000289	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.03e-05	0.000287	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VAV1—brain cancer	1.03e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL2—brain cancer	1.02e-05	0.000284	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RELA—brain cancer	1.01e-05	0.000281	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPP1—brain cancer	1.01e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ERBB2—brain cancer	1.01e-05	0.000279	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IRS2—brain cancer	1e-05	0.000277	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IRS2—brain cancer	9.94e-06	0.000276	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2C9—brain cancer	9.89e-06	0.000274	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.79e-06	0.000272	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IRS2—brain cancer	9.73e-06	0.00027	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2—brain cancer	9.66e-06	0.000268	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2—brain cancer	9.62e-06	0.000267	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ENO2—brain cancer	9.51e-06	0.000264	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCND1—brain cancer	9.42e-06	0.000261	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CTNNB1—brain cancer	9.33e-06	0.000259	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ENO2—brain cancer	9.28e-06	0.000257	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IRS2—brain cancer	9.14e-06	0.000254	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2—brain cancer	9.11e-06	0.000253	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.93e-06	0.000248	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCND1—brain cancer	8.88e-06	0.000246	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HES1—brain cancer	8.87e-06	0.000246	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APC—brain cancer	8.84e-06	0.000245	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PIK3CG—brain cancer	8.84e-06	0.000245	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CTNNB1—brain cancer	8.8e-06	0.000244	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APC—brain cancer	8.78e-06	0.000243	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PIK3CG—brain cancer	8.78e-06	0.000243	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ENO2—brain cancer	8.74e-06	0.000242	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ENO2—brain cancer	8.67e-06	0.00024	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PIK3CG—brain cancer	8.6e-06	0.000238	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APC—brain cancer	8.6e-06	0.000238	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—brain cancer	8.59e-06	0.000238	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PDGFRA—brain cancer	8.45e-06	0.000234	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BSG—brain cancer	8.41e-06	0.000233	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—brain cancer	8.21e-06	0.000228	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPP1—brain cancer	8.2e-06	0.000227	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—STAT3—brain cancer	8.13e-06	0.000225	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PIK3CG—brain cancer	8.08e-06	0.000224	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APC—brain cancer	8.08e-06	0.000224	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—brain cancer	8.05e-06	0.000223	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—brain cancer	8e-06	0.000222	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—brain cancer	7.83e-06	0.000217	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—brain cancer	7.8e-06	0.000216	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—brain cancer	7.74e-06	0.000215	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—brain cancer	7.67e-06	0.000213	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PIK3CG—brain cancer	7.56e-06	0.00021	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—brain cancer	7.55e-06	0.000209	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IRS2—brain cancer	7.41e-06	0.000206	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—brain cancer	7.39e-06	0.000205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—brain cancer	7.36e-06	0.000204	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—IDH1—brain cancer	7.23e-06	0.000201	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PIK3CG—brain cancer	7.15e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—brain cancer	7.13e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—brain cancer	6.97e-06	0.000193	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RELA—brain cancer	6.9e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB2—brain cancer	6.86e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RELA—brain cancer	6.86e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB2—brain cancer	6.82e-06	0.000189	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RELA—brain cancer	6.72e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB2—brain cancer	6.67e-06	0.000185	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APC—brain cancer	6.55e-06	0.000182	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6.55e-06	0.000182	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RELA—brain cancer	6.31e-06	0.000175	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB2—brain cancer	6.27e-06	0.000174	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—brain cancer	6.22e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—brain cancer	6.2e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—brain cancer	6.18e-06	0.000171	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCND1—brain cancer	6.06e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—brain cancer	6.05e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCND1—brain cancer	6.02e-06	0.000167	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CTNNB1—brain cancer	6e-06	0.000166	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.97e-06	0.000165	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CTNNB1—brain cancer	5.96e-06	0.000165	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCND1—brain cancer	5.9e-06	0.000164	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—brain cancer	5.85e-06	0.000162	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CTNNB1—brain cancer	5.84e-06	0.000162	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO2—brain cancer	5.72e-06	0.000159	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—brain cancer	5.68e-06	0.000158	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCND1—brain cancer	5.54e-06	0.000154	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CTNNB1—brain cancer	5.49e-06	0.000152	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—brain cancer	5.28e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—brain cancer	5.25e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—brain cancer	5.23e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—brain cancer	5.2e-06	0.000144	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—brain cancer	5.14e-06	0.000143	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RELA—brain cancer	5.12e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—brain cancer	5.09e-06	0.000141	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB2—brain cancer	5.08e-06	0.000141	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—brain cancer	4.86e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—brain cancer	4.83e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—brain cancer	4.83e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—brain cancer	4.78e-06	0.000133	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—brain cancer	4.76e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—brain cancer	4.73e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—brain cancer	4.72e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—brain cancer	4.63e-06	0.000128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—brain cancer	4.61e-06	0.000128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCND1—brain cancer	4.49e-06	0.000125	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.45e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—brain cancer	4.44e-06	0.000123	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PIK3CG—brain cancer	4.36e-06	0.000121	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—brain cancer	4.35e-06	0.000121	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PIK3CG—brain cancer	4.26e-06	0.000118	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PIK3CG—brain cancer	4.01e-06	0.000111	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—brain cancer	3.99e-06	0.000111	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PIK3CG—brain cancer	3.98e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—brain cancer	3.97e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.92e-06	0.000109	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—brain cancer	3.88e-06	0.000108	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—brain cancer	3.88e-06	0.000108	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—brain cancer	3.65e-06	0.000101	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—brain cancer	3.6e-06	9.99e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—brain cancer	3.52e-06	9.77e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—brain cancer	2.96e-06	8.21e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PIK3CG—brain cancer	2.62e-06	7.27e-05	CbGpPWpGaD
